UnknownNCT06025877
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
Studying Early-onset autosomal dominant Alzheimer disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- C2N Diagnostics
- Principal Investigator
- Mark Monane, MD, MBA, AGSFC₂N Diagnostics, LLC
- Intervention
- PrecivityAD2(TM) blood test(other)
- Enrollment
- 400 target
- Eligibility
- 55 years · All sexes
- Timeline
- 2023 – 2025
Study locations (9)
- UCSF Memory and Aging Center, San Francisco, California, United States
- Pacific Brain Health Center, Santa Monica, California, United States
- Advocate Memory Center, Park Ridge, Illinois, United States
- Josephson Wallack Munshower Neurology, P.C., Indianapolis, Indiana, United States
- Tulane Doctors Neurosurgery Clinic, New Orleans, Louisiana, United States
- Memorial Healthcare Institute for Neuroscience, Owosso, Michigan, United States
- Sharlin Health and Neurology, Ozark, Missouri, United States
- C2N Diagnostics, St Louis, Missouri, United States
- Palmetto Primary Care Physicians, Summerville, South Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06025877 on ClinicalTrials.govOther trials for Early-onset autosomal dominant Alzheimer disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05643144Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesIndiana University
- RECRUITINGNANCT07294885Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's DiseaseGeneral Hospital of Shenyang Military Region
- RECRUITINGNANCT07532590Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content.Casa di Cura Dott. Pederzoli
- ENROLLING BY INVITATIONNCT07314190Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental DisorderFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- ENROLLING BY INVITATIONNANCT07425106Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)Duke University
- RECRUITINGPHASE1NCT07328451A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's DiseaseDenali Therapeutics Inc.
- RECRUITINGPHASE1NCT07234942A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)Hoffmann-La Roche
- RECRUITINGNCT07207642Sweet Night (Musical Diffusion by Caregivers ): Effects of Musical Diffusion by Caregivers on Sleep Onset and Behavioral Regulation in a Protected LivingCentre Hospitalier Universitaire de Saint Etienne
See all trials for Early-onset autosomal dominant Alzheimer disease →